Trial Refresh: A Case for an Adaptive Platform Trial for Pulmonary Exacerbations of Cystic Fibrosis

Cystic fibrosis is a genetic disease typically characterized by progressive lung damage and premature mortality. Pulmonary exacerbations, or flare-ups of the lung disease, often require hospitalization for intensive treatment. Approximately 25% of patients with cystic fibrosis do not recover their b...

Descripción completa

Detalles Bibliográficos
Autores principales: Schultz, Andre, Marsh, Julie A., Saville, Benjamin R., Norman, Richard, Middleton, Peter G., Greville, Hugh W., Bellgard, Matthew I., Berry, Scott M., Snelling, Tom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447696/
https://www.ncbi.nlm.nih.gov/pubmed/30983998
http://dx.doi.org/10.3389/fphar.2019.00301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447696/
https://www.ncbi.nlm.nih.gov/pubmed/30983998
http://dx.doi.org/10.3389/fphar.2019.00301

Ejemplares similares